[go: up one dir, main page]

HK1215854A1 - Anti-stress agent - Google Patents

Anti-stress agent

Info

Publication number
HK1215854A1
HK1215854A1 HK16103778.4A HK16103778A HK1215854A1 HK 1215854 A1 HK1215854 A1 HK 1215854A1 HK 16103778 A HK16103778 A HK 16103778A HK 1215854 A1 HK1215854 A1 HK 1215854A1
Authority
HK
Hong Kong
Prior art keywords
stress agent
stress
agent
Prior art date
Application number
HK16103778.4A
Other languages
Chinese (zh)
Inventor
指原紀宏
長田昌士
森毅
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of HK1215854A1 publication Critical patent/HK1215854A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16103778.4A 2013-02-27 2016-04-01 Anti-stress agent HK1215854A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013037983 2013-02-27
PCT/JP2014/054629 WO2014132982A1 (en) 2013-02-27 2014-02-26 Anti-stress agent

Publications (1)

Publication Number Publication Date
HK1215854A1 true HK1215854A1 (en) 2016-09-23

Family

ID=51428245

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103778.4A HK1215854A1 (en) 2013-02-27 2016-04-01 Anti-stress agent

Country Status (5)

Country Link
JP (1) JP6329125B2 (en)
CN (1) CN105025909B (en)
HK (1) HK1215854A1 (en)
SG (1) SG11201506640TA (en)
WO (1) WO2014132982A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101937364B1 (en) * 2016-01-28 2019-01-11 경희대학교 산학협력단 Novel lactic acid bacteria having immunoregulatory activities derived from human digestive tract and use thereof
JP7248426B2 (en) * 2016-04-20 2023-03-29 株式会社明治 Fermented milk for improving subjective symptoms of summer fatigue
AU2017287989B2 (en) * 2016-06-30 2024-03-14 Asahi Group Holdings, Ltd. Composition for use in improvement of nutritional state
WO2018021435A1 (en) * 2016-07-27 2018-02-01 株式会社マイトス Composition including hydrogen as active ingredient, for improving exercise endurance or for alleviating fatigue perceived after exercise
KR20180019474A (en) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 Composition for Prevention or Treatment of Mental Disorders Comprising Extracellular Vesicles Derived from Lactic acid bacteria
JP6815139B2 (en) * 2016-09-09 2021-01-20 キリンホールディングス株式会社 Composition for suppressing age-related retinal cell death containing lactic acid bacteria as an active ingredient
EP3511011A4 (en) * 2016-09-09 2020-03-04 Kirin Holdings Kabushiki Kaisha COMPOSITION FOR PREVENTING OR IMPROVING EYE FATIGUE
JP6815410B2 (en) * 2016-10-21 2021-01-20 森永乳業株式会社 Mood profile improver
JP7134703B2 (en) * 2018-05-16 2022-09-12 株式会社明治 Adrenal hypofunction inhibitor
WO2019235451A1 (en) * 2018-06-04 2019-12-12 株式会社明治 Composition for treatment of menstrual symptom
JP2020039308A (en) * 2018-09-12 2020-03-19 キリンホールディングス株式会社 Composition for improving labor performance
JP7224586B2 (en) * 2019-01-10 2023-02-20 日本メナード化粧品株式会社 Immunity evaluation method
JP7369992B2 (en) * 2019-05-13 2023-10-27 株式会社明治 Fermented milk for improving autonomic nervous function
JP7536504B2 (en) 2019-05-31 2024-08-20 株式会社明治 Agent for improving depressive symptoms and composition containing same
EP3978075A4 (en) * 2019-06-03 2023-07-12 Asahi Group Holdings, Ltd. WALKING CAPABILITY ENHANCING AGENT
CA3151435A1 (en) * 2019-11-05 2021-05-14 Claes THULIN 4-[5-[(rac)-1-[5-(3-chlorophenyl)-3-isoxazolyl]ethoxy]-4-methyl-4<i>h</i>-1,2,4-triazol-3-yl]pyridine for use in prevention and/or treatment of surmenage in a mammal
US20230000933A1 (en) * 2019-12-02 2023-01-05 Life Quality Institute, Inc. Agent for prevention or remediation of stress disorders and composition containing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793257B1 (en) * 1999-05-06 2001-07-27 Gervais Danone Sa LACTIC BACTERIA WITH ANXIOLYTIC PROPERTIES, AND USES THEREOF
JP4853986B2 (en) * 2001-09-20 2012-01-11 雪印メグミルク株式会社 Preventive and therapeutic agent for inflammatory bowel disease and irritable bowel syndrome
JP5394628B2 (en) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 Novel Lactobacillus microorganisms and lactic acid bacteria preparations
JP2013047192A (en) * 2011-08-29 2013-03-07 Meiji Co Ltd Lactobacillus promoting physical activity
CN102726524B (en) * 2012-06-19 2014-05-28 重庆市天友乳业股份有限公司 Probiotics fermentation milk

Also Published As

Publication number Publication date
CN105025909B (en) 2020-05-19
JP6329125B2 (en) 2018-05-23
CN105025909A (en) 2015-11-04
JPWO2014132982A1 (en) 2017-02-02
WO2014132982A1 (en) 2014-09-04
SG11201506640TA (en) 2015-09-29

Similar Documents

Publication Publication Date Title
DK3689865T3 (en) Hidtil ukendte aminopyrimidinderivater
HK1215854A1 (en) Anti-stress agent
GB201311001D0 (en) Lucabella
LT3016534T (en) Footlet
EP2960327A4 (en) Immunostimulation agent
GB201411130D0 (en) Quick-coupler
GB201317658D0 (en) isizeme
GB201402358D0 (en) Salfordlock
HK1218744A1 (en) Cyanostilbenes
HK1222844A1 (en) Fluor-9-methy-b-carbolines -9---
PT3083633T (en) Spiro-oxazolones
GB201301617D0 (en) T-Monitor
EP3037100A4 (en) Muscle-atrophy-preventing agent
GB201311914D0 (en) Tu-ball
GB201311616D0 (en) Clip-gun-magazine
AU4977P (en) Harrosy Gaura lindheimeri
GB201319794D0 (en) Drawcode
GB201319734D0 (en) Aquatap
AU353326S (en) Kettlebell
GB201318627D0 (en) Laddfix
GB201317892D0 (en) LogoMyMarket
AP00812S1 (en) Stumbelbloc
GB201316071D0 (en) Boilergogo
GB201315105D0 (en) Armaclamp
GB201313296D0 (en) B-Theory

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20240225